Key result
Heart transplantation carries a ~0.2% prevalence of infective endocarditis with zero 1-year mortality.
Why the study?
Recipients of heart transplantation require prolonged immunosuppressive therapy and frequent healthcare interventions that increase infection risk, yet epidemiological data on infective endocarditis after heart transplantation are limited.
Cohort (n=1,674)
No
Answers are grounded in this paper and cite their sources.
Infective endocarditis after heart transplantation is exceedingly rare (0.2%), frequently involves the tricuspid valve in patients with pre-existing post-transplant valvulopathy, and often requires surgical repair or replacement with favorable 1-year survival.
Background Recipients of heart transplantation (HT) require prolonged immunosuppressive therapy and frequent healthcare interventions, increasing infection risk. However, the epidemiology of infective endocarditis (IE) after HT is limited.Objectives To describe the prevalence, clinical characteristics and outcomes of IE among HT recipients seen at our institution.Methods We retrospectively identified adults with possible or definite IE after HT at Mayo Clinic from 2010 through 2024 using the 2023 Duke-International Society of Cardiovascular Infectious Diseases criteria.Results This brief report presents three (0.2%) cases of possible/definite IE among 1674 HT recipients who underwent transplantation at our institution between 2010 and 2024, with an additional patient referred with IE after HT elsewhere. One case developed two months post-HT with a Candida albicans sternal wound infection, one resulted from previously unrecognised pre-HT Q fever, and two were late cases associated with bloodstream infections. The median interval from HT to IE diagnosis was 17.5 months. The tricuspid valve was involved in three patients with pre-existing post-transplant valvulopathy. One patient underwent valve replacement, while two received minimally invasive repairs. No deaths or IE relapse occurred at one-year follow-up.Conclusions IE in HT recipients is exceedingly rare. Tricuspid valve involvement and need for surgical intervention may be underrecognized.
No takes yet. Share an insight, caveat, or question.
Hindy et al. (2026) conducted a cohort in Heart transplantation recipients evaluated for infective endocarditis (n=1,674). Heart transplantation was evaluated on Prevalence of possible or definite infective endocarditis after heart transplantation. Heart transplantation was associated with a 0.2% (3/1674) prevalence of infective endocarditis, predominantly involving the tricuspid valve with 0% mortality or relapse at 1 year.
Synapse has enriched 10 related papers. Consider them for comparative context: